PO
Patrick Oeckl
Also known as: Patrick Öckl
Deutsches Zentrum für Neurodegenerative Erkrankungen eV, Standort Ulm, University Hospital Ulm
Research areas: Medicine · Neurology · Alzheimer's disease research and treatments · Dementia and Cognitive Impairment Research · Amyotrophic Lateral Sclerosis Research
Employment
-
Deutsches Zentrum für Neurodegenerative Erkrankungen eV, Standort Ulm2021 - Present
- 2013 - Present
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (109)
- Convergence of Cerebrospinal Fluid Neuronal Biomarker Burden and MRI Lesion Pattern and Its Association With Short‐Term Outcome in Neuroinfectious Diseases Save
- Tau isoform mapping across tissues and biofluids reveals a signature distinguishing Alzheimer’s disease from amyotrophic lateral sclerosis Save
- Aquaporin‐4 in Narcolepsy Type 1: Investigation of Perivascular Fluid Movement in Sleep Disorders Save
- The huntingtin–HAP40 complex is a bidirectional cellular rheostat Save
- Longitudinal changes of blood β-synuclein in cognitively unimpaired, mild cognitive impairment and sporadic Alzheimer´s disease Save
- Loss of FXR1 and FXR2 promotes accumulation of TDP-43 in aging-related stress granules Save
- Comparing loss of individual fragile X proteins suggests strong links to cellular senescence and aging Save
- Molecular aging is the main driver of Parkinson’s Disease Save
- Peptidomic analysis of CSF reveals new biomarker candidates for amyotrophic lateral sclerosis Save
- Contactin proteins in cerebrospinal fluid show different alterations in dementias Save
- Dynamics of synaptic damage in severe traumatic brain injury revealed by cerebrospinal fluid SNAP-25 and VILIP-1 Save
- Most L1CAM is not associated with extracellular vesicles in human biofluids and iPSC–derived neurons Save
- Aquaporin-4 as an early cerebrospinal fluid biomarker of Alzheimer’s disease Save
- Neurofilaments and progranulin are related to atrophy in frontotemporal lobar degeneration - A transdiagnostic study cross-validating atrophy and fluid biomarkers. Save
- CSF neurosecretory proteins VGF and neuroserpin in patients with Alzheimer's and Lewy body diseases. Save
- Increasing Phosphorylated Tau Protein Serum Levels in the Course of Chronic Heart Failure. Save
- Incremental value of serum neurofilament light chain and glial fibrillary acidic protein as blood-based biomarkers for predicting functional outcome in severe acute ischemic stroke. Save
- Quantification of blood glial fibrillary acidic protein using a second-generation microfluidic assay. Validation and comparative analysis with two established assays. Save
- Serum β-synuclein, neurofilament light chain and glial fibrillary acidic protein as prognostic biomarkers in moderate-to-severe acute ischemic stroke. Save
- High diagnostic performance of plasma and cerebrospinal fluid beta-synuclein for sporadic Creutzfeldt-Jakob disease. Save